Nicotinic and opioid receptor regulation of striatal dopamine D2-receptor mediated transmission. 2016

Aphroditi A Mamaligas, and Yuan Cai, and Christopher P Ford
Department of Neurosciences, Case Western Reserve University School of Medicine, 10900 Euclid Ave, Cleveland, OH, 44106-4970 USA.

In addition to dopamine neuron firing, cholinergic interneurons (ChIs) regulate dopamine release in the striatum via presynaptic nicotinic receptors (nAChRs) on dopamine axon terminals. Synchronous activity of ChIs is necessary to evoke dopamine release through this pathway. The frequency-dependence of disynaptic nicotinic modulation has led to the hypothesis that nAChRs act as a high-pass filter in the dopaminergic microcircuit. Here, we used optogenetics to selectively stimulate either ChIs or dopamine terminals directly in the striatum. To measure the functional consequence of dopamine release, D2-receptor synaptic activity was assessed via virally overexpressed potassium channels (GIRK2) in medium spiny neurons (MSNs). We found that nicotinic-mediated dopamine release was blunted at higher frequencies because nAChRs exhibit prolonged desensitization after a single pulse of synchronous ChI activity. However, when dopamine neurons alone were stimulated, nAChRs had no effect at any frequency. We further assessed how opioid receptors modulate these two mechanisms of release. Bath application of the κ opioid receptor agonist U69593 decreased D2-receptor activation through both pathways, whereas the μ opioid receptor agonist DAMGO decreased D2-receptor activity only as a result of cholinergic-mediated dopamine release. Thus the release of dopamine can be independently modulated when driven by either dopamine neurons or cholinergic interneurons.

UI MeSH Term Description Entries
D011957 Receptors, Opioid Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known. Endorphin Receptors,Enkephalin Receptors,Narcotic Receptors,Opioid Receptors,Receptors, Endorphin,Receptors, Enkephalin,Receptors, Narcotic,Receptors, Opiate,Endorphin Receptor,Enkephalin Receptor,Normorphine Receptors,Opiate Receptor,Opiate Receptors,Opioid Receptor,Receptors, Normorphine,Receptors, beta-Endorphin,beta-Endorphin Receptor,Receptor, Endorphin,Receptor, Enkephalin,Receptor, Opiate,Receptor, Opioid,Receptor, beta-Endorphin,Receptors, beta Endorphin,beta Endorphin Receptor,beta-Endorphin Receptors
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017448 Receptors, Dopamine D2 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES. Dopamine D2 Receptors,Dopamine-D2 Receptor,D2 Receptors, Dopamine,Dopamine D2 Receptor,Receptor, Dopamine-D2
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051676 G Protein-Coupled Inwardly-Rectifying Potassium Channels A family of inwardly-rectifying potassium channels that are activated by PERTUSSIS TOXIN sensitive G-PROTEIN-COUPLED RECEPTORS. GIRK potassium channels are primarily activated by the complex of GTP-BINDING PROTEIN BETA SUBUNITS and GTP-BINDING PROTEIN GAMMA SUBUNITS. G Protein-Activated Potassium Channels,G Protein-Coupled Inwardly-Rectifying Potassium Channel 1,G Protein-Coupled Inwardly-Rectifying Potassium Channel 2,G Protein-Coupled Inwardly-Rectifying Potassium Channel 3,G Protein-Coupled Inwardly-Rectifying Potassium Channel 4,GIRK Potassium Channels,GIRK1 Potassium Channel,GIRK2 Potassium Channel,GIRK3 Potassium Channel,GIRK4 Potassium Channel,Kir3 Potassium Channels,Kir3.1 Potassium Channel,Kir3.2 Potassium Channel,Kir3.3 Potassium Channel,Kir3.4 Potassium Channel,G Protein Activated Potassium Channels,G Protein Coupled Inwardly Rectifying Potassium Channel 1,G Protein Coupled Inwardly Rectifying Potassium Channel 2,G Protein Coupled Inwardly Rectifying Potassium Channel 3,G Protein Coupled Inwardly Rectifying Potassium Channel 4,G Protein Coupled Inwardly Rectifying Potassium Channels,Potassium Channel, GIRK1,Potassium Channel, GIRK2,Potassium Channel, GIRK3,Potassium Channel, GIRK4,Potassium Channel, Kir3.1,Potassium Channel, Kir3.2,Potassium Channel, Kir3.3,Potassium Channel, Kir3.4,Potassium Channels, GIRK,Potassium Channels, Kir3
D059329 Cholinergic Neurons Neurons whose primary neurotransmitter is ACETYLCHOLINE. Cholinergic Neuron,Neuron, Cholinergic,Neurons, Cholinergic
D062308 Optogenetics The combination of genetic and optical methods in controlling specific events with temporal precision in targeted cells of a functioning intact biological system. Optogenetic Techniques,Optogenetic,Optogenetic Technique,Technique, Optogenetic,Techniques, Optogenetic
D020875 Enkephalin, Ala(2)-MePhe(4)-Gly(5)- An enkephalin analog that selectively binds to the MU OPIOID RECEPTOR. It is used as a model for drug permeability experiments. D-Ala(2)-MePhe(4)-Gly-ol(5) Enkephalin,DAMGO,2-Ala-4-MePhe-5-Gly-Enkephalin,Ala(2)-MePhe(4)-Gly-ol(5) Enkephalin,D-Ala2-NMe-Phe4-Gly-ol Enkephalin,DAGO,DAGOL,DAMGE,Enkephalin, alanyl(2)-methylphenylalanyl(4)-glycine(5)-,RX-783006,Tyr-Ala-Gly-(NMe)Phe-Gly-ol,2 Ala 4 MePhe 5 Gly Enkephalin,D Ala2 NMe Phe4 Gly ol Enkephalin,Enkephalin, D-Ala2-NMe-Phe4-Gly-ol,RX 783006

Related Publications

Aphroditi A Mamaligas, and Yuan Cai, and Christopher P Ford
June 2015, Neurobiology of disease,
Aphroditi A Mamaligas, and Yuan Cai, and Christopher P Ford
April 1992, Annals of neurology,
Aphroditi A Mamaligas, and Yuan Cai, and Christopher P Ford
February 2012, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Aphroditi A Mamaligas, and Yuan Cai, and Christopher P Ford
July 1999, Neuroreport,
Aphroditi A Mamaligas, and Yuan Cai, and Christopher P Ford
June 2016, Neurobiology of stress,
Aphroditi A Mamaligas, and Yuan Cai, and Christopher P Ford
March 1992, Brain research,
Aphroditi A Mamaligas, and Yuan Cai, and Christopher P Ford
August 1987, Neuroscience letters,
Aphroditi A Mamaligas, and Yuan Cai, and Christopher P Ford
July 2016, Stem cell reports,
Aphroditi A Mamaligas, and Yuan Cai, and Christopher P Ford
March 2014, Neuroscience,
Aphroditi A Mamaligas, and Yuan Cai, and Christopher P Ford
December 1979, European journal of pharmacology,
Copied contents to your clipboard!